Corvus Pharmaceuticals In...

3.17
-0.01 (-0.31%)
At close: Apr 01, 2025, 3:59 PM
3.22
1.70%
After-hours: Apr 01, 2025, 07:55 PM EDT

Corvus Pharmaceuticals Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 8.74M 12.62M 13.16M 63.46M 16.45M
Short-Term Investments 43.22M 14.53M 29.14M 5.99M 27.8M
Long-Term Investments n/a 16.12M 21.88M 34.27M 37.23M
Other Long-Term Assets 13.17M 89K 1.84M 2.55M 2.4M
Receivables 75K 63K 633K 539K 86K
Inventory n/a n/a -735K -667K -492K
Other Current Assets 2.37M 220K 102K 128K 406K
Total Current Assets 54.41M 27.96M 42.3M 69.45M 44.26M
Property-Plant & Equipment 1.33M 1.39M 2.22M 3.19M 1.65M
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 14.5M 17.6M 25.94M 40M 41.27M
Total Assets 68.91M 45.55M 68.24M 109.45M 85.53M
Account Payables 2.58M 1.52M 1.98M 1.56M 3.47M
Deferred Revenue n/a n/a n/a 6.96M n/a
Short-Term Debt 185K n/a n/a n/a n/a
Other Current Liabilities 30.02M 3.29M 6.43M 5.24M 5.38M
Total Current Liabilities 35.4M 6.87M 12.13M 12.29M 13.38M
Long-Term Debt 937K n/a 1.37M 2.6M 1.23M
Other Long-Term Liabilities n/a n/a -1.37M -2.6M -1.23M
Total Long-Term Liabilities 937K n/a 1.37M 2.6M 1.23M
Total Liabilities 36.34M 6.87M 12.13M 12.29M 13.38M
Total Debt 1.12M 1.37M 2.6M 3.65M 2.31M
Common Stock 7K 5K 5K 5K 3K
Retained Earnings -397.01M -334.72M -307.69M -266.38M -223.14M
Comprehensive Income -1.29M -967K -563K 1.87M 4K
Shareholders Equity 32.57M 38.68M 56.12M 97.16M 72.15M
Total Investments 43.22M 30.65M 51.02M 40.26M 65.03M